Docket Room
SB 477·NH·senate

relative to increasing transparency in the 340B Drug Pricing Program.

In CommitteeFiled Nov 21, 2025
Sponsor: Tim McGough (R)
Latest Action

Refer to Interim Study, MA, VV; 03/05/2026; SJ 5

Mar 5, 2026

Summary

The bill mandates that hospitals, their practice locations, and contracted pharmacies in the 340B drug pricing program file an annual report on drug use, costs, reimbursements and net savings with the state health department. It also forces claim‑level 340B identifiers on all fee‑for‑service and managed‑care claims and adds rules to stop duplicate discounts. The aim is to make the program’s savings and operations clearer to the public, especially in rural areas.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SB 477 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice